An efficient and tunable parameter to improve variant calling for whole genome and exome sequencing data
- 76 Downloads
Next generation sequencing (NGS) has traditionally been performed in various fields including agricultural to clinical and there are so many sequencing platforms available in order to obtain accurate and consistent results. However, these platforms showed amplification bias when facilitating variant calls in personal genomes. Here, we sequenced whole genomes and whole exomes from ten Korean individuals using Illumina and Ion Proton, respectively to find the vulnerability and accuracy of NGS platform in the GC rich/poor area. Overall, a total of 1013 Gb reads from Illumina and ~39.1 Gb reads from Ion Proton were analyzed using BWA-GATK variant calling pipeline. Furthermore, conjunction with the VQSR tool and detailed filtering strategies, we achieved high-quality variants. Finally, each of the ten variants from Illumina only, Ion Proton only, and intersection was selected for Sanger validation. The validation results revealed that Illumina platform showed higher accuracy than Ion Proton. The described filtering methods are advantageous for large population-based whole genome studies designed to identify common and rare variations associated with complex diseases.
KeywordsWhole genome sequencing Whole exome sequencing Illumina Ion Proton Variant calling
Compliance with ethical standards
Conflict of interest
Young Ju Ahn declares that he has no conflict of interest. Kesavan Markkandan declares that he has no conflict of interest. In-Pyo Baek declares that he has no conflict of interest. Seyoung Mun declares that he has no conflict of interest. Wooseok Lee declares that he has no conflict of interest. Heui-Soo Kim declares that he has no conflict of interest. Kyudong Han declares that he has no conflict of interest.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
- Motoike IN, Matsumoto M, Danjoh I, Katsuoka F, Kojima K, Nariai N, Sato Y, Yamaguchi-Kabata Y, Ito S, Kudo H et al (2014) Validation of multiple single nucleotide variation calls by additional exome analysis with a semiconductor sequencer to supplement data of whole-genome sequencing of a human population. BMC Genom 15:673CrossRefGoogle Scholar